相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predicting the outcome of ankylosing spondylitis therapy
Nathan Vastesaeger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Body Mass Index and Clinical Response to Infliximab in Rheumatoid Arthritis
Ruth Klaasen et al.
ARTHRITIS AND RHEUMATISM (2011)
Increases in body mass index during infliximab therapy in patients with Crohn's disease: An open label prospective study
Maki Nakahigashi et al.
CYTOKINE (2011)
Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
L. Puig
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model
L. I. Cortinez et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Effect of Obesity on the Pharmacokinetics of Drugs in Humans
Michael J. Hanley et al.
CLINICAL PHARMACOKINETICS (2010)
Circulating Concentration of Infliximab and Response to Treatment in Ankylosing Spondylitis: Results From a Randomized Control Study
Roman Krzysiek et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
RHEUMATOID ARTHRITIS The multifaceted role of adiponectin in inflammatory joint disease
Ulf Mueller-Ladner et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis
Luigi Naldi et al.
DERMATOLOGY (2008)
Measurement of Nutrition Status in Crohn's Disease Patients Receiving Infliximab Therapy
Dawn Wiese et al.
NUTRITION IN CLINICAL PRACTICE (2008)
Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
Rosita Saraceno et al.
PHARMACOLOGICAL RESEARCH (2008)
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Herbert Tilg et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Efficacy and safety of infliximab in patients with ankylosing spondylitis - Results of a randomized, placebo-controlled trial (ASSERT)
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis
M Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
J Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis - Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial
EWS Clair et al.
ARTHRITIS AND RHEUMATISM (2002)
Choice of drug treatment for obesity-related hypertension: where is the evidence?
AM Sharma et al.
JOURNAL OF HYPERTENSION (2001)
Factors affecting the pharmacokinetics of CPT-11: The body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11
T Miya et al.
INVESTIGATIONAL NEW DRUGS (2001)
分享论文
